Abstract:A 59-year-old woman was admitted to our hospital for the management of refractory gastroesophageal reflux disease (GERD). Gastroscopy, ascertaining the presence of GERD, revealed a manifestation classified as LA-C, accompanied by a conspicuous abnormality in the gastroesophageal flap valve, graded as Type III ([Fig. 1]). Dynamic reflux monitoring unveiled an acid exposure time of 32%, accompanied by a DeMeester score of 144.9. Following comprehensive patient consultation, the feasibility of endoscopic anti-reflux therapy was contemplated, subsequently leading to the application of hybrid argon plasma coagulation (hAPC) in the context of anti-reflux mucosal ablation ([Video 1]). During the procedure, we initiated the delineation of the ablation territory employing hAPC, forming a horseshoe-shaped demarcation ([Fig. 2] a ). Subsequently, we executed submucosal injections directly within the marked region, utilizing hAPC ([Fig. 2] b ), followed by the argon plasma coagulation procedure atop the elevated mucosal surface ([Fig. 2] c ). Key technical nuances comprise the execution of ablation spanning a width of approximately 2–4 centimeters, with a circumferential dimension exceeding 90%, and reaching the submucosal layer's depth ([Fig. 2] d ). Postoperatively, the patient commenced a liquid diet after 24 hours; no perforation, hemorrhage, or pyrexia were encountered. One month post-procedure, mucosal flap valve reshaping was observed, resulting in the formation of an unobstructed contractile annulus ([Fig. 3]). The application of anti-reflux mucosal ablation in the management of GERD [1] has been substantiated as an efficacious and secure approach, culminating in the amelioration of GERD-related symptoms and enhancement of overall quality of life [2] [3]. A pioneering technique called hAPC amalgamates submucosal injections via a high-pressure water jet system, thereby establishing a protective cushion preceding ablation, ensuring that the ablation reaches the submucosal layer without incurring excessive harm [4]. Our utilization of hAPC in anti-reflux mucosal ablation not only attested to the achievement of submucosal ablation but also mitigated the inherent risks of perforation and postoperative stricture. To our knowledge, this represents the inaugural global case report delineating the implementation of hAPC within anti-reflux mucosal ablation for GERD management, thereby furnishing a salient reference for subsequent clinical therapeutic endeavors. Endoscopy_UCTN_Code_TTT_1AO_2AJ E-Videos is an open access online section of the journal Endoscopy , reporting on interesting cases and new techniques in gastroenterological endoscopy. All papers include a high-quality video and are published with a Creative Commons CC-BY license. Endoscopy E-Videos qualify for HINARI discounts and waivers and eligibility is automatically checked during the submission process. We grant 100% waivers to articles whose corresponding authors are based in Group A countries and 50% waivers to those who are based in Group B countries as classified by Research4Life (see: https://www.research4life.org/access/eligibility/). This section has its own submission website athttps://mc.manuscriptcentral.com/e-videos. Article published online: 23 January 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany

Application of Radiofrequency Ablation in Duodenal Mucosal Reconstruction

Numerical evaluation of the duodenal mucosal resurfacing technique for the treatment of Type 2 diabetes

Endoscopic duodenal mucosa ablation: the future of diabetes treatment?

Duodenal mucosal resurfacing: proof-of-concept, procedural development, and initial implementation in the clinical setting

Endoscopic Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes: 6-Month Interim Analysis From the First-in-Human Proof-of-Concept Study

Minireview: Current status of endoscopic duodenal mucosal resurfacing

Endoscopic duodenal mucosa ablation techniques for diabetes and nonalcoholic fatty liver disease: A systematic review

Endoscopic Duodenal Mucosal Resurfacing for the Treatment of Type 2 Diabetes

[Intraductal radiofrequency ablation under endosonography and cholangioscopy for residual adenoma of the major duodenal papilla with intraductal component]

Power-Controlled, Irrigated Radio-Frequency Ablation of Gastric Tissue: A Biophysical Analysis of Lesion Formation

Insulin sensitivity and beta cell function after Duodenal Mucosal Resurfacing (DMR): An Open-Label, Mechanistic, Pilot Study

Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes mellitus: one year results from the first international, open-label, prospective, multicentre study

Hybrid argon pasma coagulation-assisted mucosal ablation in the management of refractory gastroesophageal reflux disease

Successful removal of a duodenal lesion in difficult location using "a sandwich method"

Alternative treatments for type 2 diabetes and associated metabolic diseases: medical therapy or endoscopic duodenal mucosal remodelling?

Anti-reflux mucosal ablation for refractory gastroesophageal reflux disease after Roux-en-Y gastric bypass

Duodenal mucosal resurfacing combined with glucagon-like peptide-1 receptor agonism to discontinue insulin in type 2 diabetes: a feasibility study

Radiofrequency ablation for the management of pancreatic mass lesions

Catheter Radiofrequency Ablation of Recurrent Para-Hisian Accessary Pathways with Near Zero X-ray Exposure

Development of Radiofrequency Ablation Generator and Balloon-Based Catheter for Microendoluminal Thin-Layer Ablation Therapy Using the Rat Duodenum as a Model of Low-Impedance Tissue

Role of submucosal injection in radiofrequency ablation of gastric low-grade dysplasia: Effects on symptoms and outcomes